Abstract
Up to date, it has been reported that several bioactive natural compounds can modulate bone metabolism. It has been also disclosed that some of them simultaneously modulate the immune response. Thus, understanding the molecular mechanisms surrounding bone metabolism has moved bone research into a new era and recently the term “osteoimmunology” is coined to describe new interdisciplinary field of bone and immunology. Now, therefore bone research is one of the hot spots designing novel drugs. Notably, the role of phytoestrogens represented by isoflavones in the bone health was frequently reviewed; however only a few reviews thoroughly cover the field of bioactive natural compounds in bone metabolism. In this review, we summarize current status of representative bioactive natural compounds that modulate bone metabolism and present new therapeutic approaches in the near future by focusing on three classes of compounds phytoestrogens, polyunsaturated fatty acids and lactoferrin.
Keywords: Osteoporosis, bone, natural compounds, phytoestrogens, isoflavones, polyunsaturated fatty acids, omega-3, lactoferrin
Current Bioactive Compounds
Title: Bone Modulating Bioactive Natural Compounds: Review
Volume: 3 Issue: 3
Author(s): Kanji Mori, Dominique Heymann and Ronan Le Bot
Affiliation:
Keywords: Osteoporosis, bone, natural compounds, phytoestrogens, isoflavones, polyunsaturated fatty acids, omega-3, lactoferrin
Abstract: Up to date, it has been reported that several bioactive natural compounds can modulate bone metabolism. It has been also disclosed that some of them simultaneously modulate the immune response. Thus, understanding the molecular mechanisms surrounding bone metabolism has moved bone research into a new era and recently the term “osteoimmunology” is coined to describe new interdisciplinary field of bone and immunology. Now, therefore bone research is one of the hot spots designing novel drugs. Notably, the role of phytoestrogens represented by isoflavones in the bone health was frequently reviewed; however only a few reviews thoroughly cover the field of bioactive natural compounds in bone metabolism. In this review, we summarize current status of representative bioactive natural compounds that modulate bone metabolism and present new therapeutic approaches in the near future by focusing on three classes of compounds phytoestrogens, polyunsaturated fatty acids and lactoferrin.
Export Options
About this article
Cite this article as:
Mori Kanji, Heymann Dominique and Bot Le Ronan, Bone Modulating Bioactive Natural Compounds: Review, Current Bioactive Compounds 2007; 3 (3) . https://dx.doi.org/10.2174/157340707781695613
DOI https://dx.doi.org/10.2174/157340707781695613 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypertension, Anti-Hypertensive Therapy and Neoplasia
Current Pharmaceutical Design Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers
Current Molecular Pharmacology FOXO Transcription Factors and their Role in Disorders of the Female Reproductive Tract
Current Drug Targets Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line
Current Pharmaceutical Biotechnology Longitudinal Melatonin Production in Female Laboratory Rats During 1997-2006: Possible Modulatory Effects of Changing Solar Activity
Current Aging Science Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Current Medicinal Chemistry Leptin as Clinical Target
Recent Patents on Inflammation & Allergy Drug Discovery Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy
Current Drug Targets The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Current Clinical Pharmacology Rapid Non-genomic Vasodilator Actions of Oestrogens and Sex Steroids
Current Medicinal Chemistry Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Therapeutic Potential of Targeting PAK Signaling
Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Potential of Some Commonly Used Drugs
Current Pharmaceutical Design Multi- and Inter-Disciplinary Science in Personalized Delivery of Stem Cells for Tissue Repair
Current Stem Cell Research & Therapy A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c
Current Medicinal Chemistry High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer
Recent Patents on Anti-Cancer Drug Discovery Emerging Trends in Endometriosis Treatment - Review
Current Women`s Health Reviews Metformin and Energy Metabolism in Breast Cancer: From Insulin Physiology to Tumour-initiating Stem Cells
Current Molecular Medicine Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
Current Cancer Drug Targets